Results 11 to 20 of about 809 (171)

Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies - comprehensive analysis of anti-modified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis. [PDF]

open access: yesArthritis Res Ther
BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease characterized by the presence of autoantibodies against modified proteins, known as anti-modified protein autoantibodies (AMPAs).
van Wesemael TJ   +12 more
europepmc   +7 more sources

Rheumatoid arthritis – usage of biomarkers in disease’ prognosing, diagnosing and monitoring [PDF]

open access: yesQuality in Sport
Introduction: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease which has a significant, negative influence of patients’ quality of daily life. In routine clinical practice there is a usage of classic biomarkers, such as rheumatoid factor
Sabina Skrzynecka   +4 more
doaj   +3 more sources

Neutrophilic Activity Biomarkers (Plasma Neutrophil Extracellular Traps and Calprotectin) in Established Patients with Rheumatoid Arthritis Receiving Biological or JAK Inhibitors: A Clinical and Ultrasonographic Study [PDF]

open access: yesRheumatology and Therapy
Introduction This study assesses the accuracy of neutrophil activation markers, including neutrophil extracellular traps (NETs) and calprotectin, as biomarkers of disease activity in patients with established rheumatoid arthritis (RA).
Beatriz Frade-Sosa   +19 more
doaj   +2 more sources

Evidence of Site-Specific Mucosal Autoantibody Secretion in Rheumatoid Arthritis. [PDF]

open access: yesArthritis Rheumatol
Objective Anti–citrullinated protein antibodies (ACPA) have been detected in sputum and saliva, indicating that anti–modified protein antibodies (AMPA) can be produced at mucosal sites in patients with rheumatoid arthritis (RA). However, the body's largest mucosal compartment, the gut, has not yet been examined.
Derksen VFAM   +11 more
europepmc   +2 more sources

Research progress on anti-carbamylated protein antibodies in connective tissue disease [PDF]

open access: yesXin yixue, 2023
Connective tissue disease (CTD) is a group of chronic autoimmune diseases characterized by pathological changes in systemic organs and multisystems. The diagnosis of CTD mainly depends on clinical manifestations and specific autoantibodies.
Dong Rongrong, Yang Qingrui, Ma Zhenzhen
doaj   +1 more source

Rheumatoid arthritis and the proinflammatory cytokine IL-17 [PDF]

open access: yesFolia Medica, 2023
Introduction: Rheumatoid arthritis (RA) is the most common inflammatory joint disease. Various proinflammatory cytokines are involved in the pathogenesis of this chronic disorder.
Pavel Selimov   +8 more
doaj   +3 more sources

Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing In Vivo Epitopes of Its γ Chain One of Which Is Not Cross Reactive With Anti-Citrullinated Protein Antibodies

open access: yesFrontiers in Immunology, 2021
To identify the targets recognized by anti-carbamylated protein antibodies (anti-CarP) in patients with early Rheumatoid Arthritis (RA), to study the cross-reactivity between anti-CarP and anti-citrullinated protein antibodies (ACPA) and to evaluate ...
Pauline Brevet   +16 more
doaj   +1 more source

Detection and clinical significance of anti-carbamylated protein antibody in serologically negative patients with rheumatoid arthritis [PDF]

open access: yesXin yixue, 2022
Objective To probe into the level and clinical significance of anti-carbamylated protein (CarP) antibody in serologically negative patients with rheumatoid arthritis (RA).
Wu Tao, Chen Chutao, Yang Lijuan, Zou Yaowei, Ma Jianda, Xu Yanhui, Jia Lei, Dai Lie
doaj   +1 more source

A matter arising: When should inflammatory and autoimmune rheumatic diseases be considered 'early'? [PDF]

open access: yesEur J Clin Invest
Timely recognition of inflammatory and autoimmune rheumatic diseases (IARDs) is important to optimize the early diagnosis with tailored interventions and possible prevention of irreversible organ damage. This narrative review provides an update by summarizing the advances in identifying the early stages of rheumatoid arthritis, systemic sclerosis and ...
Hysa E   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy